Putting the Microenvironment into the Immunotherapy Companion Diagnostic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33986024.
- Also identified by DOI 10.1158/1078-0432.CCR-21-1238.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A <i>post hoc</i> analysis in advanced gastric cancer showed stronger association of programmed cell death-ligand 1 (PD-L1) with immunotherapy efficacy measured by combined positive score (CPS) compared with tumor cells (TC%). This finding suggests expression in immune cells in the tumor microenvironment increases the value of the companion diagnostic test.<i>See related article by Lei et al., p. 3926</i>.
Medical subject headings
- B7-H1 Antigen
- Stomach Neoplasms